Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
86,879,403
-
Share change
-
-13,744,980
-
Total reported value
-
$31,098,479
-
Put/Call ratio
-
435%
-
Price per share
-
$0.36
-
Number of holders
-
126
-
Value change
-
-$5,527,369
-
Number of buys
-
55
-
Number of sells
-
68
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2024
As of 30 Jun 2024,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,879,403 shares.
The largest 10 holders included
WASATCH ADVISORS LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.